Raymond James Financial’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
+26,412
New +$1.25M ﹤0.01% 3875
2026
Q1
– Sell
-30,622
Closed -$2.82M – 5365
2025
Q4
$2.82M Buy
+30,622
New +$2.93M ﹤0.01% 2988
2025
Q3
– Sell
-230,153
Closed -$29.9M – 5818
2025
Q2
$29.9M Sell
230,153
-6,343
-3% -$920K 0.01% 1092
2025
Q1
$37.7M Sell
236,496
-20,296
-8% -$3.67M 0.01% 879
2024
Q4
$47.6M Buy
+256,792
New +$49.8M 0.02% 754

Other funds holding INSP

Raymond James Financial's INSP Position: Q2 2026 in Review

Raymond James Financial opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 26,412 shares worth $1.18M. The stake represents ﹤0.01% of the portfolio and ranks #3875 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in INSP as recently as Q4 2025.

Raymond James Financial first reported a position in INSP in Q4 2024 and has held it in 5 quarters since. The position peaked at $47.6M in Q4 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Raymond James Financial held 26,412 shares of Inspire Medical Systems worth $1.18M as of Q2 2026.
  • Inspire Medical Systems was a new Raymond James Financial position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3875 holding.
  • Raymond James Financial first reported a position in Inspire Medical Systems in Q4 2024 and has held it in 5 quarters since.
  • Raymond James Financial's Inspire Medical Systems position peaked at $47.6M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.